Submission Details
| 510(k) Number | K193051 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | November 01, 2019 |
| Decision Date | January 29, 2020 |
| Days to Decision | 89 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
K193051 is an FDA 510(k) clearance for the LIAISON Lyme Total Antibody Plus, LIAISON Lyme Total Antibody Plus Control Set, a Reagent, Borrelia Serological Reagent (Class II — Special Controls, product code LSR), submitted by DiaSorin, Inc. (Stillwater,, US). The FDA issued a Cleared decision on January 29, 2020, 89 days after receiving the submission on November 1, 2019. This device falls under the Microbiology review panel. Regulated under 21 CFR 866.3830.
| 510(k) Number | K193051 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | November 01, 2019 |
| Decision Date | January 29, 2020 |
| Days to Decision | 89 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
| Product Code | LSR — Reagent, Borrelia Serological Reagent |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 866.3830 |